“ANALYSIS OF FINANCIAL PERFORMANCE OF PHARMACY COMPANIES DURING THE COVID-19 PANDEMIC” (2023) INTERNATIONAL SEMINAR, 5, pp. 340–347. doi:10.36563/proceeding.v5i0.136.